Modulation of components of ATP–adenosine metabolism is a potential approach for cancer immunotherapy; options include inhibition of adenosine-generating enzymes (ATPase, AMPase), degradation of extracellular adenosine, and blockade of adenosine receptors [28–30]. Here, DNAH8 is linked to cancer.